AI filing briefs · archive

8-K filings in January 2024, explained

73 material Form 8-K filings that 66 companies we cover made with the SEC in January 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

2 of 73 briefs match

newest first · times in ET

PLXSPLEXUS CORP Jan 24, 4:21 PM ET

Plexus Q1 revenue falls to $983 million and Q2 guidance comes in below prior outlook

Negative earnings Written later 2.02

Plexus reported fiscal first quarter 2024 revenue of $983 million and GAAP diluted EPS of $1.04, down from $1.09 billion and $1.49 a year earlier. Its fiscal second quarter guidance of $930 million to $970 million in revenue and $0.48 to $0.63 in GAAP diluted EPS is lower than the October 2023 guidance, and the company expects restructuring charges that weigh on those results, so shareholders face weaker near-term earnings.

Q1 fiscal 2024 revenue of $983 million vs. $1,094 million a year earlier; GAAP diluted EPS of $1.04 vs. $1.49
Q2 guidance: revenue of $930 million to $970 million and GAAP diluted EPS of $0.48 to $0.63, vs. October 25, 2023 guidance of $990 million to $1.03 billion and EPS of $1.15 to $1.33
Restructuring charges of approximately $10 million ($0.32 per share) expected in Q2, with about $20 million of annualized cost savings targeted by fiscal Q3
Board approved a new $50.0 million share repurchase program, which starts after the current authorization with $5.7 million remaining is completed

Read the filing on SEC.gov ↗

ELVElevance Health, Inc. Jan 24, 6:04 AM ET

Elevance Health Q4 2023 revenue rises 7% to $42.5 billion; 2024 EPS outlook above $34.29

Positive earnings Written later 2.02

Elevance Health reported fourth-quarter and full-year 2023 results in a press release furnished under Item 2.02 of this 8-K. Quarterly operating revenue rose 7.0% to $42.5 billion and GAAP diluted EPS rose 1.1% to $3.63, while the company set a full-year 2024 GAAP diluted EPS outlook of greater than $34.29, compared with $25.22 for 2023, and raised its quarterly dividend 10.1% to $1.63 per share.

4Q 2023 operating revenue $42.5 billion, up 7.0%; GAAP diluted EPS $3.63, up 1.1%; adjusted diluted EPS $5.62, up 15.2%
FY 2024 GAAP diluted EPS outlook greater than $34.29; adjusted diluted EPS outlook greater than $37.10, versus FY 2023 GAAP diluted EPS of $25.22
Quarterly dividend increased 10.1% to $1.63 per share
4Q 2023 operating margin was 3.0%, down from 3.2% in 4Q 2022

Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.